Study on All-Trans Retinoic Acid (ATRA) and PD-1 Inhibitor for Recurrent IDH-Mutant Glioma | Clinical Trial

Study on All-Trans Retinoic Acid (ATRA) and PD-1 Inhibitor for Recurrent IDH-Mutant Glioma | Clinical Trial | Right2Hope